Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes.

ABSTRACT:

Objective

Chronic diabetic foot ulcers are a source of major concern for both patients and health care systems. The aim of this study was to evaluate the effect of hyperbaric oxygen therapy (HBOT) in the management of chronic diabetic foot ulcers.

Research design and methods

The Hyperbaric Oxygen Therapy in Diabetics with Chronic Foot Ulcers (HODFU) study was a randomized, single-center, double-blinded, placebo-controlled clinical trial. The outcomes for the group receiving HBOT were compared with those of the group receiving treatment with hyperbaric air. Treatments were given in a multi-place hyperbaric chamber for 85-min daily (session duration 95 min), five days a week for eight weeks (40 treatment sessions). The study was performed in an ambulatory setting.

Results</

SUBMITTER: Londahl M 

PROVIDER: S-EPMC2858204 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature